ArticleJournal of clinical medicine2019

MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma.

Cristian Turato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.